European Society of Cardiology

Medications

Analysis hints at sudden cardiac death reduction with finerenone

Finerenone does not reduce the risk of all-cause death in patients with type 2 diabetes and kidney disease but does lower the likelihood of sudden cardiac death, according to late breaking research presented in a Hot Line ...

page 14 from 40